ERBB2 and neoplasm: The rs3803662 genotype has been shown to associate most strongly with the ER/PgR positive and ERBB2 negative subgroups[21], which is the expression pattern of tumours of the luminal A subtype, further supporting that the effect seen in the BCAC study may be connected to luminal A tumours.